PATENT CLAIM ANALYSIS

Application Number: 15911496
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "465000"]

Abstract:
The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.

Claim (Index 37):
The method of  claim 21 , wherein the patient suffers from difficulties in sleep efficiency.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 90.0
- Lexical Diversity: 1.1
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15394912', '13898364', '15344710', '11804720', '14917125']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6800560262454645
- 35 USC 102 Novelty (BERT): 0.548558133013511
- Combined Prediction Score: 0.6669062369222691
- Mean Citation Score: 300.531608
- Max Citation Score: 399.25385
- Similarity Product: 232.2896197225362

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test